Medical Market Report

Global Liquid Biopsy Market By Type (Ctc, Ctdna, and Exosomes), By Application (Blood Sample Based, Urine Sample Based, and Bio Fluids Based), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 135273
  • 16-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Liquid Biopsy Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global liquid biopsy market is segmented on the basis of Type, Application, and geography.
    The worldwide market for Liquid Biopsy Market is expected to grow at a CAGR of roughly x.x% over the next ten years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.

    Liquid Biopsy Market Scope:

    By type, the market is segmented into CTC, ctDNA, and Exosomes. By Application, the market is divided into Blood Sample based, Urine Sample based, and Bio Fluids based.
    Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include RainDanceTechnologies, Biocartis, Guardant Health, MDxHealth, Pathway Genomics, NeoGenomics Laboraories, Sysmex Inostics, Cynvenio, Menarini Silicon Biosystems, Qiagen, Adaptive Biotechnologies, Biocept, and Angle plc.

    Key Market Segments

    Type

    CTC
    ctDNA
    Exosomes

    Application

    Blood Sample based
    Urine Sample based
    Bio Fluids based

    Key Market Players included in the report:

    RainDanceTechnologies
    Biocartis
    Guardant Health
    MDxHealth
    Pathway Genomics
    NeoGenomics Laboraories
    Sysmex Inostics
    Cynvenio
    Menarini Silicon Biosystems
    Qiagen
    Adaptive Biotechnologies
    Biocept
    Angle plc

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Liquid Biopsy Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Liquid Biopsy Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Liquid Biopsy Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Liquid Biopsy Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Liquid Biopsy Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Liquid Biopsy Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Liquid Biopsy sub-markets, depending on key regions (various vital states).
    To analyze Liquid Biopsy Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Liquid Biopsy Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
    Primary worldwide Liquid Biopsy Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Liquid Biopsy Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

    2.1. Key Findings by Major Segments
    
2.2. Top strategies by Major Players3. Global Liquid Biopsy Market Overview
    

    3.1. Liquid Biopsy Market Dynamics
    

    3.1.1. Drivers
    
3.1.2. Opportunities
    
3.1.3. Restraints
    
3.1.4. Challenges3.2. PESTLE Analysis
    
3.3. Opportunity Map Analysis
    
3.4. PORTER’S Five Forces Analysis
    
3.5. Market Competition Scenario Analysis
    
3.6. Product Life Cycle Analysis
    
3.7. Opportunity Orbits
    
3.8. Manufacturer Intensity Map4. Global Liquid Biopsy Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

    4.1. Global Liquid Biopsy Market Analysis by Type: Introduction
    
4.2. Market Size and Forecast by Region
    
4.3. CTC
    
4.4. ctDNA
    
4.5. Exosomes5. Global Liquid Biopsy Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

    5.1. Global Liquid Biopsy Market Analysis by Application: Introduction
    
5.2. Market Size and Forecast by Region
    
5.3. Blood Sample based
    
5.4. Urine Sample based
    
5.5. Bio Fluids based6. Global Liquid Biopsy Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

    6.1. North America
    

    6.1.1. North America Liquid Biopsy Market: Regional Trend Analysis
    

    6.1.1.1. US
    
6.1.1.2. Canada
    
6.1.1.3. Mexico
    

    6.2.1. Europe
    

    6.2.1. Europe Liquid Biopsy Market: Regional Trend Analysis
    

    6.2.1.1. Germany
    
6.2.1.2. France
    
6.2.1.3. UK
    
6.2.1.4. Russia
    
6.2.1.5. Italy
    
6.2.1.6. Rest of Europe
    

    6.3. Asia-Pacific
    

    6.3.1. Asia-Pacific Liquid Biopsy Market: Regional Trend Analysis
    

    6.3.1.1. China
    
6.3.1.2. Japan
    
6.3.1.3. Korea
    
6.3.1.4. India
    
6.3.1.5. Rest of Asia
    

    6.4. Latin America
    

    6.4.1. Latin America Liquid Biopsy Market: Regional Trend Analysis
    

    6.4.1.1. Brazil
    
6.4.1.2. Argentina
    
6.4.1.3. Rest of Latin America
    

    6.5. Middle East and Africa
    

    6.5.1. Middle East and Africa Liquid Biopsy Market: Regional Trend Analysis
    

    6.5.1.1. GCC
    
6.5.1.2. South Africa
    
6.5.1.3. Israel
    
6.5.1.4. Rest of MEA
    
7. Global Liquid Biopsy Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

    7.1. Market Share Analysis
    
7.2. Company Profiles
    
7.3. RainDanceTechnologies
    

    7.3.1. Company Overview
    
7.3.2. Financial Highlights
    
7.3.3. Product Portfolio
    
7.3.4. SWOT Analysis
    
7.3.5. Key Strategies and Developments7.4. Biocartis
    

    7.4.1. Company Overview
    
7.4.2. Financial Highlights
    
7.4.3. Product Portfolio
    
7.4.4. SWOT Analysis
    
7.4.5. Key Strategies and Developments7.5. Guardant Health
    

    7.5.1. Company Overview
    
7.5.2. Financial Highlights
    
7.5.3. Product Portfolio
    
7.5.4. SWOT Analysis
    
7.5.5. Key Strategies and Developments7.6. MDxHealth
    

    7.6.1. Company Overview
    
7.6.2. Financial Highlights
    
7.6.3. Product Portfolio
    
7.6.4. SWOT Analysis
    
7.6.5. Key Strategies and Developments7.7. Pathway Genomics
    

    7.7.1. Company Overview
    
7.7.2. Financial Highlights
    
7.7.3. Product Portfolio
    
7.7.4. SWOT Analysis
    
7.7.5. Key Strategies and Developments7.8. NeoGenomics Laboraories
    

    7.8.1. Company Overview
    
7.8.2. Financial Highlights
    
7.8.3. Product Portfolio
    
7.8.4. SWOT Analysis
    
7.8.5. Key Strategies and Developments7.9. Sysmex Inostics
    

    7.9.1. Company Overview
    
7.9.2. Financial Highlights
    
7.9.3. Product Portfolio
    
7.9.4. SWOT Analysis
    
7.9.5. Key Strategies and Developments7.10. Cynvenio
    

    7.10.1. Company Overview
    
7.10.2. Financial Highlights
    
7.10.3. Product Portfolio
    
7.10.4. SWOT Analysis
    
7.10.5. Key Strategies and Developments7.11. Menarini Silicon Biosystems
    

    7.11.1. Company Overview
    
7.11.2. Financial Highlights
    
7.11.3. Product Portfolio
    
7.11.4. SWOT Analysis
    
7.11.5. Key Strategies and Developments7.12. Qiagen
    

    7.12.1. Company Overview
    
7.12.2. Financial Highlights
    
7.12.3. Product Portfolio
    
7.12.4. SWOT Analysis
    
7.12.5. Key Strategies and Developments7.13. Adaptive Biotechnologies
    

    7.13.1. Company Overview
    
7.13.2. Financial Highlights
    
7.13.3. Product Portfolio
    
7.13.4. SWOT Analysis
    
7.13.5. Key Strategies and Developments7.14. Biocept
    

    7.14.1. Company Overview
    
7.14.2. Financial Highlights
    
7.14.3. Product Portfolio
    
7.14.4. SWOT Analysis
    
7.14.5. Key Strategies and Developments7.15. Angle plc
    

    7.15.1. Company Overview
    
7.15.2. Financial Highlights
    
7.15.3. Product Portfolio
    
7.15.4. SWOT Analysis
    
7.15.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.